Pages that link to "Q89108153"
Jump to navigation
Jump to search
The following pages link to Cornelia L. Dekker (Q89108153):
Displaying 50 items.
- Cytomegalovirus infection enhances the immune response to influenza. (Q30300254) (← links)
- Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS. (Q30354452) (← links)
- Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements (Q30364187) (← links)
- Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination. (Q30368005) (← links)
- Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies (Q30405145) (← links)
- Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons (Q30419062) (← links)
- Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine (Q30422951) (← links)
- Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination (Q30426121) (← links)
- Baseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines (Q33348541) (← links)
- Influence of prior influenza vaccination on antibody and B-cell responses (Q33361605) (← links)
- Randomized, placebo-controlled trial to assess the safety and immunogenicity of an adenovirus type 35-based circumsporozoite malaria vaccine in healthy adults (Q34170122) (← links)
- The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors (Q34313957) (← links)
- Distinct cross-reactive B-cell responses to live attenuated and inactivated influenza vaccines (Q34354440) (← links)
- Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy. (Q34407590) (← links)
- Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults (Q34498228) (← links)
- Characterization of influenza vaccine immunogenicity using influenza antigen microarrays. (Q34755553) (← links)
- Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine (Q34763836) (← links)
- Genetic measurement of memory B-cell recall using antibody repertoire sequencing (Q34880392) (← links)
- B-cell repertoire responses to varicella-zoster vaccination in human identical twins (Q34985620) (← links)
- Variation in the human immune system is largely driven by non-heritable influences (Q34998817) (← links)
- Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults (Q35148060) (← links)
- Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults (Q35557123) (← links)
- Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. (Q35634295) (← links)
- Attitudes and beliefs of parents concerned about vaccines: impact of timing of immunization information (Q35953676) (← links)
- Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine (Q35993484) (← links)
- IgH sequences in common variable immune deficiency reveal altered B cell development and selection (Q36096339) (← links)
- Defective T Memory Cell Differentiation after Varicella Zoster Vaccination in Older Individuals (Q36169646) (← links)
- Human B-cell isotype switching origins of IgE (Q36563625) (← links)
- Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection (Q36612933) (← links)
- Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution (Q36751110) (← links)
- Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals (Q36853115) (← links)
- Apoptosis and other immune biomarkers predict influenza vaccine responsiveness (Q36856669) (← links)
- Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination (Q36882923) (← links)
- Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination (Q36931965) (← links)
- Lineage structure of the human antibody repertoire in response to influenza vaccination (Q36975946) (← links)
- Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine (Q37020189) (← links)
- Lineage tracing of human B cells reveals the in vivo landscape of human antibody class switching (Q37146773) (← links)
- An algorithm for treatment of patients with hypersensitivity reactions after vaccines (Q37258051) (← links)
- Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination (Q37495044) (← links)
- Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells (Q37538022) (← links)
- Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry (Q37569278) (← links)
- Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires (Q37625782) (← links)
- Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination (Q37635478) (← links)
- Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states (Q37658834) (← links)
- Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans (Q37711867) (← links)
- Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004–2009 (Q37908267) (← links)
- Biologically plausible and evidence-based risk intervals in immunization safety research (Q38029858) (← links)
- Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). (Q38051944) (← links)
- Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults (Q38392346) (← links)
- Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines (Q39320852) (← links)